Cléry
VC Fund
Paris, France
Cléry is an investing vehicle that funds environmentally and socially responsible projects.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Cléry invests in
Stages Cléry invests in
Countries Cléry invests in
Investment Focus
Industry
- Health Care 4 (67%)
- Medical 2 (33%)
- AgTech 1 (17%)
- Winery 1 (17%)
- Farming 1 (17%)
Stage
- Seed 2 (33%)
- Series A 1 (17%)
- Series B 1 (17%)
- Funding Round 1 (17%)
- Venture - Series Unknown 1 (17%)
Country
- France 5 (83%)
- India 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| NeoFarm is a project that focuses on producing fresh, local, organic veggies in urban areas. | $35.4M / Series B / Jun 30, 2025 | ||
| Primaa is a MedTech company offering an AI-based platform for automated and accurate cancer diagnosis. Leveraging image analysis and deep learning, our technology enhances the detection of major cancer biomarkers and guide personalized treatment. | $5M / Seed / Nov 18, 2024 | ||
| dEchoTech is a small-to-medium sized French company located near Paris and has been funded in part by the CNES (French Agency for Space Studies). It was founded in 2008 by Dr. Éric Lefebvre, a well-known ultrasound radiologist. Éric has more than 25 years of experience practicing ultrasonography in private practices and in hospitals. He is afrequent contributor at conferences and in discipline-specific national and international journals. Today, Éric is President of the company while continuing to practice as a radiologist to stay close in touch with what’s happening in the field – knowledge that is especially crucial to have in the biomedical industry. Our strength lies in involving the medical community at the very beginning design stages to ensure our solutions best meet the needs of end users. Solutions designed by doctors, to support doctors, and to improve public health. | $4.4M / Oct 09, 2024 | ||
| HEPTA Medical develops a sensor, embedded into a bronchoscopic or percutaneous ablation catheter, which provides temperature-based feedback. This enables real-time dosing to precisely target and ablates pulmonary nodules, the precursor of lung cancer, without the need for surgery or radiation. | $6.3M / Series A / Sep 04, 2024 | ||
| Onafis is a company that provides digital solutions for tracking each stage of winemaking in real time on wines, beers, and spirits, adaptable to different types of containers. | $6.4M / Venture - Series Unknown / Jun 11, 2024 | ||
| Clarity is a clinical-stage company pioneering a new category of non-pharmacological treatments for neurodegenerative diseases. We develop a neuromodulation device combining immersive technology, AI and biosensors to deliver gamma sensory stimulation. Gamma waves’ sensory stimulation has been shown to significantly slow down Alzheimer'sprogression, reducing neurodegeneration and cognitive decline. Clarity takes a platform approach by enabling the customization of sensory stimulation protocols based on patient data, improving experience, efficacy and scalability across a wide range of indications. The company was founded by neuroscientists from UC Berkeley, and Oxford along with execs from OURA and Philips, and is supported by leading institutions such as UCSF's Neuroscape. | Seed / Apr 15, 2024 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Cléry invest in?
Cléry invests primarily in Health Care, Medical and AgTech startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Cléry last invest?
The most recent investment recorded for Cléry closed in Jun 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
